The National Administration of Medicines, Food, and Medical Technology (ANMAT) issued Provision 236/2026, which establishes the mechanisms for certifying compliance with quality, safety, and efficacy requirements for the importation and marketing within the national territory of certain low- and medium-risk products, within the framework of Decree 892/2025, which recognizes certifications issued by internationally recognized health authorities.
Access the complete text of the Provision here.
This publication does not constitute legal advice on specific matters. If necessary, specialized legal advice should be sought.
For more information, please contact:
Agustín Siboldi – SiboldiA@eof.com.ar
Jorge Muratorio – MuratorioJ@eof.com.ar